Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

Nature

Volumn 446, Issue 7137, 2007, Pages 758-764

  Mullighan, Charles G ^a   Goorha, Salil ^a   Radtke, Ina ^a   Miller, Christopher B ^a   Coustan Smith, Elaine ^a   Dalton, James D ^a   Girtman, Kevin ^a   Mathew, Susan ^a,b   Ma, Jing ^a   Pounds, Stanley B ^a   Su, Xiaoping ^a   Pui, Ching Hon ^a   Relling, Mary V ^a   Evans, William E ^a   Shurtleff, Sheila A ^a   Downing, James R ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IKAROS TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR PAX5;

BLOOD SYSTEM DISORDER; CANCER; CHROMOSOME; GENETIC ANALYSIS; GENOME; MUTATION;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA SEQUENCE; GENE; GENE AMPLIFICATION; GENE DELETION; GENE DISRUPTION; GENE MUTATION; GENE TARGETING; GENE TRANSLOCATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOME; HUMAN; LEUKEMIA CELL; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PAX5 GENE; POINT MUTATION; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 34147224008     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05690     Document Type: Review

References (38)

1. Greaves, M. F. & Wiemels, J. Origins of chromosome translocations in childhood leukaemia. Nature Rev. Cancer 3, 639-649 (2003).
2. Peters, U. R. et al. Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia. Oncogene 18, 79-85 (1999).
3. Jackson, A. et al. Deletion of 6q16-q21 in human lymphoid malignancies: a mapping and deletion analysis. Cancer Res. 60, 2775-2779 (2000).
4. Okuda, T. et al. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood 85, 2321-2330 (1995).
5. Raynaud, S. et al. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 87, 2891-2899 (1996).
6. Raimondi, S. C. et al. Acute lymphoblastic leukemias with deletion of 11q23 or a novel inversion (11)(p13q23) lack MLL gene rearrangements and have favorable clinical features. Blood 86, 1881-1886 (1995).
7. Heerema, N. A. et al. Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemia. J. Clin. Oncol. 18, 3837-3844 (2000).
8. Cave, H. et al. Deletion of chromosomal region 13q14.3 in childhood acute lymphoblastic leukemia. Leukemia 15, 371-376 (2001).
9. Lin, H. & Grosschedl, R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376, 263-267 (1995).
10. Ehrich, M. et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc. Natl Acad. Sci. USA 102, 15785-15790 (2005).
11. Nutt, S. L., Heavey, B., Rolink, A. G. & Busslinger, M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401, 556-562 (1999).
12. Busslinger, M. Transcriptional control of early B cell development. Annu. Rev. Immunol. 22, 55-79 (2004).
13. Ying, H., Healy, J. I., Goodnow, C. C. & Parnes, J. R. Regulation of mouse CD72 gene expression during B lymphocyte development. J. Immunol. 161, 4760-4767 (1998).
14. Cazzaniga, G. et al. The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case. Cancer Res. 61, 4666-4670 (2001).
15. Strehl, S., Konig, M., Dworzak, M. N., Kalwak, K. & Haas, O. A. PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13). Leukemia 17, 1121-1123 (2003).
16. Bohlander, S. K. ETV6: a versatile player in leukemogenesis. Semin. Cancer Biol. 15, 162-174 (2005).
17. Wlodarska, I. et al. FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations. Leukemia 19, 1299-1305 (2005).
18. Bond, H. M. et al. Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells. Blood 103, 2062-2070 (2004).
19. Hu, H. et al. Foxp1 is an essential transcriptional regulator of B cell development. Nature Immunol. 7, 819-826 (2006).
20. Warming, S. et al. Evi3, a common retroviral integration site in murine B-cell lymphoma, encodes an EBFAZ-related Kruppel-like zinc finger protein. Blood 101, 1934-1940 (2003).
21. Garvie, C. W., Hagman, J. & Wolberger, C. Structural studies of Ets-1/Pax5 complex formation on DNA. Mol. Cell 8, 1267-1276 (2001).
22. Czerny, T. & Busslinger, M. DNA-binding and transactivation properties of Pax-6: three amino acids in the paired domain are responsible for the different sequence recognition of Pax-6 and BSAP (Pax-5). Mol. Cell. Biol. 15, 2858-2871 (1995).
23. Maier, H., Colbert, J., Fitzsimmons, D., Clark, D. R. & Hagman, J. Activation of the early B-cell-specific mb-1 (Ig-alpha) gene by Pax-5 is dependent on an unmethylated Ets binding site. Mol. Cell. Biol. 23, 1946-1960 (2003).
24. Nutt, S. L., Morrison, A. M., Dorfler, P., Rolink, A. & Busslinger, M. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J. 17, 2319-2333 (1998).
25. Ross, M. E. et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 102, 2951-2959 (2003).
26. ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53. Oncogene 24, 1461-1466 (2005).
27. Conte, N. et al. Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulators. Oncogene 21, 5619-5630 (2002).
28. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
29. Georgopoulos, K. et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell 79, 143-156 (1994).
30. O'Riordan, M. & Grosschedl, R. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 11, 21-31 (1999).
31. Winandy, S., Wu, P. & Georgopoulos, K. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83, 289-299 (1995).
32. Nutt, S. L. et al. Independent regulation of the two Pax5 alleles during B-cell development. Nature Genet. 21, 390-395 (1999).
33. Robson, E. J., He, S. J. & Eccles, M. R. A. PANorama of PAX genes in cancer and development. Nature Rev. Cancer 6, 52-62 (2006).
34. Busslinger, M., Klix, N., Pfeffer, P., Graninger, P. G. & Kozmik, Z. Deregulation of PAX-5 by translocation of the Eμ enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma. Proc. Natl Acad. Sci. USA 93, 6129-6134 (1996).
35. Matsuzaki, H. et al. Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nature Methods 1, 109-111 (2004).
36. Lin, M. et al. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 20, 1233-1240 (2004).
37. Olshen, A. B., Venkatraman, E. S., Lucito, R. & Wigler, M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5, 557-572 (2004).
38. McCarroll, S. A. et al. Common deletion polymorphisms in the human genome. Nature Genet. 38, 86-92 (2006).